Concepedia

Kimberly West-Osterfield

KW

3

Publications

129

Citations

3

H-Index

2010

Active since

Affiliations

Tennessee Oncology(Current)

Grand Rapids Community College

Kimberly West-Osterfield is an author at Tennessee Oncology specializing in medicine, cancer therapeutics, and radiation oncology.

Top concepts

MedicineGliomaOncologyCell BiologyPharmacologyTumor BiologyCancer BiologyCancer TherapyCell SignalingNeuro-oncology

Publications per year

2010–2019

3

Publications

3

Paclitaxel/Carboplatin/Etoposide Versus Gemcitabine/Irinotecan in the First-Line Treatment of Patients With Carcinoma of Unknown Primary Site

John D. Hainsworth, David R. Spigel, Bobby L. Clark et al. · The Cancer Journal · 2010 · 66 citations

Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II)

John D. Hainsworth, Kevin Becker, Tarek Mekhail et al. · Journal of Neuro-Oncology · 2019 · 49 citations

Neuro-oncology, Oncology, Phase Ii +10

MB0 and MBI Are Independent and Distinct Transactivation Domains in MYC that Are Essential for Transformation

Qin Zhang, Kimberly West-Osterfield, Erick Spears et al. · Genes · 2017 · 14 citations · Full text

Molecular Biology, Cancer Biology, Tumor Biology +17

Rows per page

1–3 of 3